DK1157987T3 - S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser - Google Patents

S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser

Info

Publication number
DK1157987T3
DK1157987T3 DK00900518T DK00900518T DK1157987T3 DK 1157987 T3 DK1157987 T3 DK 1157987T3 DK 00900518 T DK00900518 T DK 00900518T DK 00900518 T DK00900518 T DK 00900518T DK 1157987 T3 DK1157987 T3 DK 1157987T3
Authority
DK
Denmark
Prior art keywords
nitrosothiols
agents
treatment
circulatory disorders
circulatory
Prior art date
Application number
DK00900518T
Other languages
English (en)
Inventor
Moliner Jose Repolles
Perez-Rasilla Eduardo Salas
Coy Francisco Pubill
Rofes Cristina Negrie
Llorente Lydia Cabeza
Siso Alicia Ferrer
Adroher Nuria Trias
Banus Marcel Li Carbo
Moreno Jesos Murat
Llaguno Pedro Michelena
Riudavets Juan Antonio Cerda
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Application granted granted Critical
Publication of DK1157987T3 publication Critical patent/DK1157987T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK00900518T 1999-01-27 2000-01-19 S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser DK1157987T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009900159A ES2147162B1 (es) 1999-01-27 1999-01-27 "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias".
PCT/ES2000/000019 WO2000044714A1 (es) 1999-01-27 2000-01-19 S-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias

Publications (1)

Publication Number Publication Date
DK1157987T3 true DK1157987T3 (da) 2003-11-24

Family

ID=8307080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900518T DK1157987T3 (da) 1999-01-27 2000-01-19 S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser

Country Status (37)

Country Link
US (1) US6800612B2 (da)
EP (1) EP1157987B1 (da)
JP (1) JP3795330B2 (da)
KR (1) KR100671878B1 (da)
CN (1) CN1166631C (da)
AP (1) AP1439A (da)
AT (1) ATE249428T1 (da)
AU (1) AU764725B2 (da)
BG (1) BG64983B1 (da)
BR (1) BR0007395B1 (da)
CA (1) CA2359027C (da)
CU (1) CU23098A3 (da)
CZ (1) CZ298871B6 (da)
DE (2) DE60005154T2 (da)
DK (1) DK1157987T3 (da)
EA (1) EA003577B1 (da)
EE (1) EE04524B1 (da)
ES (2) ES2147162B1 (da)
GB (1) GB2363604B (da)
GE (1) GEP20043220B (da)
HK (1) HK1043586A1 (da)
HR (1) HRP20010562B1 (da)
HU (1) HUP0105203A3 (da)
ID (1) ID29777A (da)
IL (1) IL144381A (da)
IS (1) IS2153B (da)
MX (1) MXPA01007570A (da)
NO (1) NO326806B1 (da)
NZ (1) NZ513162A (da)
OA (1) OA11823A (da)
PL (1) PL202372B1 (da)
PT (1) PT1157987E (da)
RS (1) RS50072B (da)
SI (1) SI1157987T1 (da)
TR (1) TR200102003T2 (da)
WO (1) WO2000044714A1 (da)
ZA (1) ZA200106182B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173044B1 (es) * 2001-03-13 2004-01-16 Lacer Sa Derivados de glicina, n-(n-l-gamma-glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
CA2539973A1 (en) * 2003-09-26 2005-04-07 Nitromed, Inc. Nitrosated glutamic acid compounds, compositions and methods of use
EP1939179A1 (en) * 2006-12-28 2008-07-02 Lacer, S.A. Stable S-nitrosothiols, method of synthesis and use
PL2197417T3 (pl) 2007-10-17 2012-08-31 Pharmagenix Ag Kompozycja farmaceutyczna zawierająca S-nitrozoglutation i polisacharyd

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US37839A (en) * 1863-03-03 Improved spoke-machine
GB1567561A (en) 1977-01-18 1980-05-14 Ucb Sa Amino-spiro(oxa-(orthia)cycloalkane-penam) - carboxylic acids
GB2052497B (en) 1979-06-25 1983-06-29 Ucb Sa 6 - amino - spiro - (penam - 2,4' - piperidine) - 3 - carboxylic acid derivatives
DE3805965A1 (de) 1988-02-25 1989-09-07 Tamas Geb Szenasi Eszter Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
US5025001A (en) 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
EP0412699B1 (en) * 1989-08-07 1994-04-27 Takeda Chemical Industries, Ltd. Nitrosothiol derivatives, their production and use
ATE145919T1 (de) 1990-04-26 1996-12-15 Senju Pharma Co Inhibitor von lebererkrankungen
US5187305A (en) * 1990-11-26 1993-02-16 Glaxo Inc. S-nitroso-N-alkonoylpenicillamines
AU3071592A (en) 1991-11-14 1993-06-15 Brigham And Women's Hospital Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
NZ248332A (en) 1992-08-07 1995-01-27 Sankyo Co Hiv protease inhibitor and its use
CA2170772C (en) * 1993-09-17 2005-03-29 Jonathan Stamler Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
PT726768E (pt) 1993-11-02 2000-11-30 Us Health Utilizacao de compostos libertadores de acido nitrico para o fabrico de um medicamento para proteccao na lesao por isquemia-reperfusao
GB9423868D0 (en) 1994-11-25 1995-01-11 Wellcome Found Compounds for use in medicine
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
AU6782198A (en) 1997-03-27 1998-10-20 Trustees Of Boston University Novel antiplatelet agent

Also Published As

Publication number Publication date
JP3795330B2 (ja) 2006-07-12
NO20013385L (no) 2001-09-17
CZ298871B6 (cs) 2008-02-27
CZ20012678A3 (cs) 2001-10-17
YU53601A (sh) 2004-03-12
KR100671878B1 (ko) 2007-01-19
AU764725B2 (en) 2003-08-28
EA200100823A1 (ru) 2002-02-28
ATE249428T1 (de) 2003-09-15
GB0120581D0 (en) 2001-10-17
CU23098A3 (es) 2005-11-18
NO20013385D0 (no) 2001-07-06
BG64983B1 (bg) 2006-11-30
IS6020A (is) 2001-07-23
PL349006A1 (en) 2002-06-17
DE10083902T1 (de) 2002-01-10
SI1157987T1 (en) 2004-02-29
HRP20010562B1 (en) 2010-08-31
DE60005154D1 (de) 2003-10-16
US20020058629A1 (en) 2002-05-16
ID29777A (id) 2001-10-11
HUP0105203A2 (en) 2002-06-29
EE04524B1 (et) 2005-08-15
CN1166631C (zh) 2004-09-15
ZA200106182B (en) 2002-10-28
US6800612B2 (en) 2004-10-05
AU3046000A (en) 2000-08-18
BG105824A (en) 2002-06-28
GB2363604A (en) 2002-01-02
CA2359027C (en) 2008-10-28
WO2000044714A1 (es) 2000-08-03
CA2359027A1 (en) 2000-08-03
HK1043586A1 (zh) 2002-09-20
AP2001002247A0 (en) 2001-09-30
NZ513162A (en) 2003-01-31
PT1157987E (pt) 2004-01-30
EE200100389A (et) 2002-12-16
CN1337946A (zh) 2002-02-27
ES2147162A1 (es) 2000-08-16
HRP20010562A2 (en) 2002-08-31
EP1157987A1 (en) 2001-11-28
ES2206178T3 (es) 2004-05-16
KR20010101767A (ko) 2001-11-14
NO326806B1 (no) 2009-02-16
EP1157987B1 (en) 2003-09-10
BR0007395B1 (pt) 2010-11-16
TR200102003T2 (tr) 2001-12-21
JP2002535385A (ja) 2002-10-22
IS2153B (is) 2006-10-13
OA11823A (en) 2005-08-16
AP1439A (en) 2005-06-27
DE60005154T2 (de) 2004-07-08
IL144381A (en) 2005-08-31
BR0007395A (pt) 2001-10-30
GB2363604B (en) 2003-09-10
HUP0105203A3 (en) 2002-08-28
PL202372B1 (pl) 2009-06-30
MXPA01007570A (es) 2003-05-14
ES2147162B1 (es) 2001-03-16
GEP20043220B (en) 2004-04-26
EA003577B1 (ru) 2003-06-26
RS50072B (sr) 2009-01-22
IL144381A0 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DK2412368T3 (da) Sammensætning til behandling af ar
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
EE200200172A (et) Ühendid isheemia ravimiseks
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
NO20044054L (no) Administrering av midler for behandling av betennelse
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
DK1434588T3 (da) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
DK1225890T3 (da) Rivastigmin til behandling af öjensygdomme
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser